documents: FDA-2025-P-3575-0003

Regulatory documents from Regulations.gov including rules, proposed rules, notices, and supporting materials.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id agency_id docket_id title document_type subtype posted_date posted_year posted_month comment_start_date comment_end_date last_modified fr_doc_num open_for_comment withdrawn object_id
FDA-2025-P-3575-0003 FDA FDA-2025-P-3575 Determination That TOLECTIN DS (Tolmetin Sodium) Capsule, Equivalent to 400 Milligrams Base, Was Not Withdrawn From Sale for Reasons of Safety or Effectiveness Notice Determinations 2026-02-18T05:00:00Z 2026 2     2026-02-18T19:03:46Z 2026-03213 0 0 09000064b91b901e

Links from other tables